OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(14)
Publication Date
Release Date
2024
(4)
2025
(3)
2023
(3)
2021
(2)
2022
(1)
2019
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis.
Not available
S-EPMC11322833
|
biostudies-literature
Cite
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
Not available
S-EPMC6398890
|
biostudies-literature
Cite
Allyl Isothiocyanate Suppresses the Proliferation in Oral Squamous Cell Carcinoma via Mediating the KDM8/CCNA1 Axis.
Not available
S-EPMC10604360
|
biostudies-literature
Cite
Deciphering Bacterial Community Succession and Pathogen Dynamics in ICU Ventilator Circuits Through Full-Length 16S rRNA Sequencing for Mitigating the Risk of Nosocomial Infections.
Not available
S-EPMC12471920
|
biostudies-literature
Cite
Non-cystic fibrosis bronchiectasis in Taiwan.
Not available
S-EPMC12496070
|
biostudies-literature
Cite
Eradicating <i>Helicobacter pylori</i> via <sup>13</sup>C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
Not available
S-EPMC12056587
|
biostudies-literature
Cite
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Not available
S-EPMC8252422
|
biostudies-literature
Cite
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Not available
S-EPMC10776298
|
biostudies-literature
Cite
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.
Not available
S-EPMC8648748
|
biostudies-literature
Cite
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naive patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Not available
S-EPMC10042416
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets